Aug 14, 2026 04:05PM
Aug 3, 2026 08:30AM
Aug 3, 2026 08:30AM
Jul 13, 2026 08:31AM
Jul 13, 2026 08:30AM
Jun 2, 2026 04:05PM
Jun 2, 2026 04:05PM Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
May 14, 2026 04:09PM
May 14, 2026 04:07PM
Apr 30, 2026 04:15PM
Apr 30, 2026 04:15PM
Apr 30, 2026 04:07PM
Apr 30, 2026 04:05PM
Apr 22, 2026 08:37AM Cue Biopharma implements 1-for-30 reverse stock split
Apr 22, 2026 08:37AM
Apr 15, 2026 08:01AM
Apr 15, 2026 08:00AM
Apr 8, 2026 08:00AM
Apr 8, 2026 08:00AM
Mar 27, 2026 04:05PM
Mar 27, 2026 04:05PM Cue Biopharma Announces CEO Transition
Mar 26, 2026 08:00AM
Mar 16, 2026 04:05PM
Mar 9, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 12, 2026 08:02AM
Feb 12, 2026 08:00AM
Nov 12, 2025 04:05PM Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Nov 6, 2025 08:02AM
Nov 6, 2025 08:00AM
Sep 29, 2025 09:00AM
Sep 29, 2025 09:00AM
Aug 13, 2025 08:00AM
Aug 12, 2025 04:05PM
Jul 16, 2025 08:00AM Cue Biopharma reports additional response in head and neck cancer trial
Jul 16, 2025 08:00AM
Jul 1, 2025 04:05PM
Jul 1, 2025 04:05PM
Jun 24, 2025 04:48PM
Jun 24, 2025 04:48PM
May 12, 2025 04:05PM
May 8, 2025 08:00AM Cue Biopharma to Host Virtual Investor Event on May 15, 2025
Apr 14, 2025 05:00PM
Apr 14, 2025 05:00PM
Mar 31, 2025 04:20PM
Nov 14, 2024 04:05PM
Nov 14, 2024 08:00AM
Nov 8, 2024 01:31PM
Nov 8, 2024 01:30PM Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
Sep 9, 2024 08:03AM

329,957 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All